Asthma Respiratory Asthma
Conditions
Interventions
‘AsthmaMD’ was developed by Dr Sam Pejham, a physician and researcher from the University of California San Francisco, Medical School Clinical Faculty. ‘AsthmaMD’ allows users to log their peak flow m
this is at the users’ discretion. No other physical or informational materials are provided to participants as part of the intervention. The intervention duration is 2 weeks based on recent feasibilit
Sponsors
National University of Ireland
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age between 18-30 years on date of recruitment 2. Diagnosis of asthma 3. Current prescription for any form of ICS 4. Own a smartphone
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Usability of the app is measured using the System Usability Scale (SUS) at 2-week follow-up 2. Acceptability of the app measured using questions modified from previous feasibility studies of mHealth interventions (Huang et al., 2019; Zhang et al., 2019) at 2-week follow-up 3. Feasibility of the app measured using frequently used questions modified from previous feasibility studies of mHealth interventions (Edbrooke-Childs et al., 2019; Escobar-Viera et al., 2020; Hightow-Weidman et al., 2018; Huang et al., 2019; Zhang et al., 2019) at 2-week follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Source of recruitment measured by asking participants how they heard about the study at baseline 2. Attrition measured using the number of participants who consent to participate and who remain in the study until the end of follow-up at 2 weeks 3. Adherence to ICS measured using the Medication Adherence Report Scale for Asthma (MARS-A) at baseline and 2-week follow-up 4. Asthma control measured using the Asthma Control Test (ACT) at baseline and 2-week follow-up | — |
Countries
Ireland
Contacts
Public ContactJane Murphy
Outcome results
None listed